Stężenie witaminy D w surowicy nie jest związane z aktywnością spondyloartropatii zapalnych.
Data nadesłania: 29-09-2018
Data ostatniej rewizji: 30-11--0001
Data akceptacji: 01-12-2018
Data publikacji online: 23-12-2018
Data publikacji: 23-12-2018
Reumatologia 2018;56(6):388-391
Vitamin D plays an important role in mineral turnover and bone remodeling and there are increasing data about its immunomodulatory potential in different rheumatologic disorders. Deficiency of vitamin D is frequent in patients with spondyloarthritis (SpA) and some data suggest its association with increased disease activity and structural damage. However, its exact role in the pathogenesis of SpA and its association with disease activity are still a matter of debate.

Material and methods:
A cross-sectional study of patients diagnosed with axial spondyloarthritis (axSpA) and peripheral spondyloarthritis (perSpA) according to Assessment of Spondyloarthritis International Society classification criteria was performed. The correlation between concentration of 25-hydroxyvitamin D – 25(OH)D – and disease activity scores (Bath Ankylosing Spondylitis Disease Activity Index – BASDAI, Ankylosing Spondylitis Disease Activity Score – ASDAS), inflammatory markers (C-reactive protein – CRP, erythrocyte sedimentation rate – ESR) and clinical symptoms (arthritis, enthesitis, dactylitis) was performed.

We included 40 patients with axSpA and 23 patients with perSpA. The mean concentration of 25(OH)D was 24.9 ng/ml (SD 12.49). Forty-seven (74.6%) patients had 25(OH)D below the recommended threshold (< 30 ng/ml). We found no statistically significant negative correlation between the level of 25(OH)D and disease activity of axSpA and perSpA in terms of clinical symptoms (arthritis, enthesitis, dactylitis), inflammatory markers (ESR, CRP) and disease activity scores (BASDAI, ASDAS). These results did not change after adjustment for supplementation of vitamin D and seasonal variation.

Our data show no correlation between the concentration of 25(OH)D in the serum and disease activity in two subgroups of SpA. However, this does not exclude the potential role of vitamin D in pathogenesis of SpA. Further studies are required to evaluate the optimal range of 25(OH)D serum concentration in axSpA and perSpA patients with its possible immunomodulatory potential and influence on disease activity.

Erten S, Kucuksahin O, Sahin A, et al. Decreased Plasma Vitamin D Levels in Patients with Undifferentiated Spondyloarthritis and Ankylosing Spondylitis. Intern Med 2013; 52: 339-344.
Mermerci Baskan B, Pekin Dogan Y, Sivas F, et al. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 2010; 30: 375-381.
Zhao S, Thong D, Duffield S, et al. Vitamin D Deficiency in Axial Spondyloarthritis is Associated With Higher Disease Activity. Arch Rheumatol 2017; 32: 209-215.
Hmamouchi I, Paternotte S, Molto A, et al. Vitamin D, disease activity and comorbidities in early spondyloarthritis. Clin Exp Rheumatol 2016; 34: 396-403.
Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system. Nat Rev Immunol 2008; 8: 685-698.
Melis L, Elewaut D. Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease? Arthritis Res Ther 2009; 11: 233.
Guła Z, Stec M, Rutkowska Zapała M, et al. The absolute number of circulating nonclassical (CD14+CD16++) monocytes negatively correlates with DAS28 and swollen joint count in patients with peripheral spondyloarthritis. Pol Arch Intern Med 2017; 127: 846-853.
Du T, Zhou ZG, You S, et al. Regulation by 1,25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 2009; 402: 133-138.
Dickie LJ, Church LD, Coulthard LR, et al. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology 2010; 49: 1466-1471.
Guillot X, Prati C, Wendling D. Vitamin D and spondyloarthritis. Expert Rev Clin Immunol 2014; 10: 1581-1589.
Arends S, Spoorenberg A, Bruyn GAW, et al. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 2011; 22: 1431-1439.
Klingberg E, Oleröd G, Hammarsten O, et al. The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study. Osteoporos Int 2016; 27: 2027-2033.
Hewison M, Freeman L, Hughes SV, et al. Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells. J Immunol 2003; 170: 5382-5390.
Fritsche J, Mondal K, Ehrnsperger A, et al. Regulation of 25-hydroxyvitamin D3-1-hydroxylase and production of 1, 25-dihydroxyvitamin D3 by human dendritic cells. Clin Endocrinol (Oxf) 2003; 102: 3314-3316.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top